 Connection
Karen Rossmassler to Drug Therapy, Combination
This is a "connection" page, showing publications Karen Rossmassler has written about Drug Therapy, Combination.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.172 |
|
|
|
-
Wynn EA, Dide-Agossou C, Al Mubarak R, Rossmassler K, Hendrix J, Voskuil MI, Obregón-Henao A, Lyons MA, Robertson GT, Moore CM, Walter ND. Deconvoluting drug interactions using M. tuberculosis physiologic processes: transcriptional disaggregation of the BPaL regimen in vivo. Antimicrob Agents Chemother. 2025 Nov 05; 69(11):e0049225.
Score: 0.048
-
Lyons MA, Obregon-Henao A, Ramey ME, Bauman AA, Pauly S, Rossmassler K, Reid J, Karger B, Walter ND, Robertson GT. Use of multiple pharmacodynamic measures to deconstruct the Nix-TB regimen in a short-course murine model of tuberculosis. Antimicrob Agents Chemother. 2024 05 02; 68(5):e0101023.
Score: 0.043
-
Wynn EA, Dide-Agossou C, Reichlen M, Rossmassler K, Al Mubarak R, Reid JJ, Tabor ST, Born SEM, Ransom MR, Davidson RM, Walton KN, Benoit JB, Hoppers A, Loy DE, Bauman AA, Massoudi LM, Dolganov G, Strong M, Nahid P, Voskuil MI, Robertson GT, Moore CM, Walter ND. Transcriptional adaptation of Mycobacterium tuberculosis that survives prolonged multi-drug treatment in mice. mBio. 2023 Dec 19; 14(6):e0236323.
Score: 0.042
-
Dide-Agossou C, Bauman AA, Ramey ME, Rossmassler K, Al Mubarak R, Pauly S, Voskuil MI, Garcia-Cremades M, Savic RM, Nahid P, Moore CM, Tasneen R, Nuermberger EL, Robertson GT, Walter ND. Combination of Mycobacterium tuberculosis RS Ratio and CFU Improves the Ability of Murine Efficacy Experiments to Distinguish between Drug Treatments. Antimicrob Agents Chemother. 2022 04 19; 66(4):e0231021.
Score: 0.038
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|